Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
55.97
+2.86 (5.39%)
Feb 27, 2026, 12:14 PM EST - Market open
Dianthus Therapeutics Employees
Dianthus Therapeutics had 78 employees as of December 31, 2024. The number of employees increased by 25 or 47.17% compared to the previous year.
Employees
78
Change (1Y)
25
Growth (1Y)
47.17%
Revenue / Employee
$39,462
Profits / Employee
-$1,619,808
Market Cap
2.42B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 78 | 25 | 47.17% |
| Dec 31, 2023 | 53 | 21 | 65.63% |
| Jun 30, 2023 | 43 | - | - |
| Mar 31, 2023 | 32 | - | - |
| Dec 31, 2022 | 32 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,869 |
| Ultragenyx Pharmaceutical | 1,294 |
| Telix Pharmaceuticals | 1,184 |
| Arcus Biosciences | 627 |
| Ascentage Pharma Group International | 605 |
| Galapagos NV | 558 |
| Ocular Therapeutix | 325 |
| Immunome | 168 |
DNTH News
- 3 days ago - Dianthus Therapeutics to Participate in The TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 10 days ago - Dianthus Therapeutics, Inc. (DNTH) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript - Seeking Alpha
- 22 days ago - Dianthus Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - GlobeNewsWire
- 6 weeks ago - Dianthus Therapeutics, Inc. (DNTH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - Dianthus Therapeutics To Participate in the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Leads Biolabs And Dianthus Therapeutics Announce Initiation of Phase 1 Trial Of LBL-047 (DNTH212) In Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE) - GlobeNewsWire
- 3 months ago - Dianthus Therapeutics To Participate in the 8th Annual Evercore Healthcare Conference - GlobeNewsWire
- 4 months ago - Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results - GlobeNewsWire